Bernhard J. Jank
Department Of Otorhinolaryngology And Head And Neck Surgery
Vienna, Austria
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Evaluation of the Naples Prognostic Score in Patients with Head and Neck Squamous Cell Carcinoma.
Journal: Nutrients
Published: February 20, 2026
The ATR inhibitor berzosertib acts as a radio- and chemosensitizer in head and neck squamous cell carcinoma cell lines.
Journal: Investigational new drugs
Published: October 05, 2023
High USP4 mRNA is associated with an HPV-positive status in head and neck squamous cell carcinoma patients.
Journal: Journal of cancer research and clinical oncology
Published: April 27, 2023
Low free triiodothyronine and immune-related hyperthyroidism are associated with overall and progression-free survival in head and neck squamous cell carcinoma treated with pembrolizumab.
Journal: International immunopharmacology
Published: April 25, 2023
Early on-treatment C-reactive protein and its kinetics predict survival and response in recurrent and/or metastatic head and neck cancer patients receiving first-line pembrolizumab.
Journal: Investigational new drugs
Published: March 03, 2023
Targeting TGF beta receptor 1 in head and neck squamous cell carcinoma.
Journal: Oral diseases
Published: January 16, 2023
The Geriatric Nutritional Risk Index (GNRI) as a Prognostic Biomarker for Immune Checkpoint Inhibitor Response in Recurrent and/or Metastatic Head and Neck Cancer.
Journal: Nutrients
Published: January 06, 2023
The prognostic role of PSMD14 in head and neck squamous cell carcinoma.
Journal: Journal of cancer research and clinical oncology
Published: May 10, 2022
Radiogenomic markers enable risk stratification and inference of mutational pathway states in head and neck cancer.
Journal: European journal of nuclear medicine and molecular imaging
Published: April 26, 2022
The radiosensitizing effect of β-Thujaplicin, a tropolone derivative inducing S-phase cell cycle arrest, in head and neck squamous cell carcinoma-derived cell lines.
Journal: Investigational new drugs
Published: January 07, 2022
Protein Expression of Folate Receptor Alpha in Adenoid Cystic Carcinoma of the Head and Neck.
Journal: OncoTargets and therapy
Published: December 20, 2021
Prognostic Relevance of Thyroid-Hormone-Associated Proteins in Adenoid Cystic Carcinoma of the Head and Neck.
Journal: Journal of personalized medicine
Published: November 05, 2021
Last Updated: 09/26/2026